U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756294) titled 'Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease' on Aug. 05.
Brief Summary: The purpose of this study is to find out what effects (good and bad) the study medications (insulin or Empagliflozin) have on adults with mild memory impairment or early Alzheimer's disease who are clinically prescribed an anti-amyloid therapy compared to placebo.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Alzheimer Disease
Intervention:
DRUG: Empagliflozin
empagliflozin 10 mg every day
DRUG: Insulin
Intranasal insulin 40 international units four times daily
DRUG: Insulin Placeb...